BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17605038)

  • 21. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
    Eramo MJ; Mitchell CA
    Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling.
    Vinciguerra M; Foti M
    Arch Physiol Biochem; 2006 Apr; 112(2):89-104. PubMed ID: 16931451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian inositol polyphosphate 5-phosphatase II can compensate for the absence of all three yeast Sac1-like-domain-containing 5-phosphatases.
    O'Malley CJ; McColl BK; Kong AM; Ellis SL; Wijayaratnam AP; Sambrook J; Mitchell CA
    Biochem J; 2001 May; 355(Pt 3):805-17. PubMed ID: 11311145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
    Harris SJ; Parry RV; Westwick J; Ward SG
    J Biol Chem; 2008 Feb; 283(5):2465-9. PubMed ID: 18073217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
    Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
    J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.
    Ramos AR; Ghosh S; Erneux C
    J Lipid Res; 2019 Feb; 60(2):276-286. PubMed ID: 30194087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TPIP: a novel phosphoinositide 3-phosphatase.
    Walker SM; Downes CP; Leslie NR
    Biochem J; 2001 Dec; 360(Pt 2):277-83. PubMed ID: 11716755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leading-edge research: PtdIns(3,4,5)P3 and directed migration.
    Franca-Koh J; Kamimura Y; Devreotes PN
    Nat Cell Biol; 2007 Jan; 9(1):15-7. PubMed ID: 17199126
    [No Abstract]   [Full Text] [Related]  

  • 31. Signalling through phosphoinositide 3-kinases: the lipids take centre stage.
    Leevers SJ; Vanhaesebroeck B; Waterfield MD
    Curr Opin Cell Biol; 1999 Apr; 11(2):219-25. PubMed ID: 10209156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
    Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
    J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Function of Inositol Phosphatases in Plant Tolerance to Abiotic Stress.
    Jia Q; Kong D; Li Q; Sun S; Song J; Zhu Y; Liang K; Ke Q; Lin W; Huang J
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench.
    Wishart MJ; Taylor GS; Slama JT; Dixon JE
    Curr Opin Cell Biol; 2001 Apr; 13(2):172-81. PubMed ID: 11248551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease.
    Davies EM; Sheffield DA; Tibarewal P; Fedele CG; Mitchell CA; Leslie NR
    Subcell Biochem; 2012; 58():281-336. PubMed ID: 22403079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
    Ramos AR; Elong Edimo W; Erneux C
    Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
    Steelman LS; Bertrand FE; McCubrey JA
    Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INPP4B: the new kid on the PI3K block.
    Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
    Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.